These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 31062416)

  • 1. In perspective: An update on telomere targeting in cancer.
    Sugarman ET; Zhang G; Shay JW
    Mol Carcinog; 2019 Sep; 58(9):1581-1588. PubMed ID: 31062416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overcoming the immortality of tumour cells by telomere and telomerase based cancer therapeutics--current status and future prospects.
    Kelland LR
    Eur J Cancer; 2005 May; 41(7):971-9. PubMed ID: 15862745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of telomere dysfunction mediated by the telomerase substrate precursor 6-thio-2'-deoxyguanosine.
    Mender I; Gryaznov S; Dikmen ZG; Wright WE; Shay JW
    Cancer Discov; 2015 Jan; 5(1):82-95. PubMed ID: 25516420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation and Effect of Telomerase and Telomeric Length in Stem Cells.
    Celtikci B; Erkmen GK; Dikmen ZG
    Curr Stem Cell Res Ther; 2021; 16(7):809-823. PubMed ID: 32321410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Telomere Length Maintenance in Cancer: At the Crossroad between Telomerase and Alternative Lengthening of Telomeres (ALT).
    De Vitis M; Berardinelli F; Sgura A
    Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29463031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The role of alternative lengthening of telomeres mechanisms in carcinogenesis and prospects for using an anti-telomerase drugs in malignant tumors treatment].
    Grach AA
    Tsitologiia; 2011; 53(10):759-71. PubMed ID: 22232932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis and treatment of ALT tumors: is Trabectedin a new therapeutic option?
    Pompili L; Leonetti C; Biroccio A; Salvati E
    J Exp Clin Cancer Res; 2017 Dec; 36(1):189. PubMed ID: 29273061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oligonucleotides and G-quadruplex stabilizers: targeting telomeres and telomerase in cancer therapy.
    Crees Z; Girard J; Rios Z; Botting GM; Harrington K; Shearrow C; Wojdyla L; Stone AL; Uppada SB; Devito JT; Puri N
    Curr Pharm Des; 2014; 20(41):6422-37. PubMed ID: 24975605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Telomerase inhibitors and 'T-oligo' as cancer therapeutics: contrasting molecular mechanisms of cytotoxicity.
    Rankin AM; Faller DV; Spanjaard RA
    Anticancer Drugs; 2008 Apr; 19(4):329-38. PubMed ID: 18454043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA methylation mediated up-regulation of TERRA non-coding RNA is coincident with elongated telomeres in the human placenta.
    Novakovic B; Napier CE; Vryer R; Dimitriadis E; Manuelpillai U; Sharkey A; Craig JM; Reddel RR; Saffery R
    Mol Hum Reprod; 2016 Nov; 22(11):791-799. PubMed ID: 27604461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Telomerase inhibitor imetelstat has preclinical activity across the spectrum of non-small cell lung cancer oncogenotypes in a telomere length dependent manner.
    Frink RE; Peyton M; Schiller JH; Gazdar AF; Shay JW; Minna JD
    Oncotarget; 2016 May; 7(22):31639-51. PubMed ID: 27192120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Roles of telomeres and telomerase in cancer, and advances in telomerase-targeted therapies.
    Jafri MA; Ansari SA; Alqahtani MH; Shay JW
    Genome Med; 2016 Jun; 8(1):69. PubMed ID: 27323951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of telomerase and viruses interaction in cancer development, and telomerase-dependent therapeutic approaches.
    Salimi-Jeda A; Badrzadeh F; Esghaei M; Abdoli A
    Cancer Treat Res Commun; 2021; 27():100323. PubMed ID: 33530025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alternative lengthening of telomeres in the human adrenocortical carcinoma cell line H295R.
    Fujiwara M; Kamma H; Wu W; Yano Y; Homma S; Satoh H
    Int J Oncol; 2006 Aug; 29(2):445-51. PubMed ID: 16820888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Telomerase: a potential therapeutic target for cancer.
    Fletcher TM
    Expert Opin Ther Targets; 2005 Jun; 9(3):457-69. PubMed ID: 15948667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional Loss of
    Graham MK; Kim J; Da J; Brosnan-Cashman JA; Rizzo A; Baena Del Valle JA; Chia L; Rubenstein M; Davis C; Zheng Q; Cope L; Considine M; Haffner MC; De Marzo AM; Meeker AK; Heaphy CM
    Mol Cancer Res; 2019 Dec; 17(12):2480-2491. PubMed ID: 31611308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Telomerase- and alternative telomere lengthening-independent telomere stabilization in a metastasis-derived human non-small cell lung cancer cell line: effect of ectopic hTERT.
    Brachner A; Sasgary S; Pirker C; Rodgarkia C; Mikula M; Mikulits W; Bergmeister H; Setinek U; Wieser M; Chin SF; Caldas C; Micksche M; Cerni C; Berger W
    Cancer Res; 2006 Apr; 66(7):3584-92. PubMed ID: 16585183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting telomeres: advances in telomere maintenance mechanism-specific cancer therapies.
    Gao J; Pickett HA
    Nat Rev Cancer; 2022 Sep; 22(9):515-532. PubMed ID: 35790854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alternative Lengthening of Telomeres Mediated by Mitotic DNA Synthesis Engages Break-Induced Replication Processes.
    Min J; Wright WE; Shay JW
    Mol Cell Biol; 2017 Oct; 37(20):. PubMed ID: 28760773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of reconstitution of telomerase activity on telomere maintenance by the alternative lengthening of telomeres (ALT) pathway.
    Grobelny JV; Kulp-McEliece M; Broccoli D
    Hum Mol Genet; 2001 Sep; 10(18):1953-61. PubMed ID: 11555632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.